HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder/Karan licensing deal provides international platform for Donna Karan expansion.

This article was originally published in The Rose Sheet

Executive Summary

LAUDER/KARAN LICENSING AGREEMENT TO ELIMINATE $7 MIL. BEAUTY DEBT the apparel maker would have recorded for the year if no deal had been struck, the fashion house said. The agreement will allow Donna Karan to "substantially eliminate its loss" from the beauty business, the company said. Under the strategic licensing agreement announced jointly by the companies Sept. 30, Estee Lauder will obtain exclusive worldwide rights to Donna Karan's international trademarks. Lauder will control the manufacturing, marketing, distribution and sale of all Karan beauty and beauty-related products. Terms of the Lauder deal, which begins officially in February, were not disclosed.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel